Pharmacokinetic Characteristics and Clinical Implications of Remifentanil

Pharmacokinetic Parameters

In adult patients receiving continuous infusions of any duration (up to at least 12 hours), the context‑sensitive half‑life and the 50 % decrement time of remifentanil are essentially identical, averaging 3–4 minutes; this rapid offset is unique among opioids. 1
After a 3‑hour infusion, the 50 % decrement time of remifentanil is measured at approximately 3.2 minutes, and the pharmacodynamic offset (time to recovery of minute ventilation) is about 5.4 minutes. 2

Remifentanil is hydrolyzed by nonspecific plasma and tissue esterases, not by hepatic enzymes, resulting in metabolism that is independent of liver function. 1
The drug’s systemic clearance is roughly 40 mL min⁻¹ kg⁻¹ (≈250–300 L h⁻¹), which is 3–4 times greater than normal hepatic blood flow, underscoring its ultra‑rapid elimination. (Citation not required for this statement as it lacks a reference.)

Opioid	Context‑Sensitive Half‑Life (after 3 h infusion)	Terminal Elimination Half‑Life
Remifentanil	3–4 minutes [1][2]	3–10 minutes [1]
Alfentanil	50–55 minutes (no citation)	76.5 minutes (no citation)
Fentanyl	200 minutes (≈6 h) / 300 minutes (≈12 h) [1][2]	2–4 hours [1][2]
Sufentanil	33.9 minutes (no citation)	Not specified (no citation)

The table highlights that remifentanil’s context‑sensitive half‑life remains markedly shorter than the terminal elimination half‑life of other commonly used opioids, confirming its uniquely predictable and rapid offset. [1][2]

Abrupt discontinuation of remifentanil can precipitate opioid‑induced hyperalgesia and an opioid withdrawal syndrome, especially in patients with prolonged exposure. 3
Prospective strategies—such as transitioning to longer‑acting opioids, employing regional anesthesia, or using non‑opioid analgesics—are recommended to mitigate these risks when stopping remifentanil. 4